Mapping cytosine modifications
View Patent ↗Methods, compositions and kits for selectively altering and detecting modified cytosine residues are provided.
1. A composition comprising a reducing agent capable of converting 5-formylcytosine or 5-carboxycytosine to 5-hydroxymethylcytosine; T4 β-glucosyltransferase (BGT) and a UDP derivative selected from the group consisting of UDP-glucose and UDP-azidoglucose.
2. A composition according to claim 1 , further comprising a nucleic acid.
3. A kit comprising a reducing agent capable of converting 5-formylcytosine or 5-carboxycytosine to 5-hydroxymethylcytosine; T4 β-glucosyltransferase (BGT); and a UDP derivative selected from the group consisting of UDP-glucose and UDP-azidoglucose.
4. A kit according to claim 3 , further comprising UDP-glucosamine.
5. A kit according to claim 3 , further comprising a nucleic acid.
6. A kit according to any claim 3 , further comprising an oxidizing agent that is capable of oxidizing 5-methylcytosine to 5-hydroxymethylcytosine.